Health-related quality of life outcomes and economic burden of inflammatory bowel disease in Japan
Kaoru Yamabe,1 Ryan Liebert,2 Natalia Flores,2 Chris L Pashos3 1Healthcare Policy and Access, Takeda Pharmaceutical Company Limited, Nihonbashi, Chuouku, Tokyo 103-8668, Japan; 2Health Outcomes Research, Kantar Health, New York, NY 10010, USA; 3Global Outcomes and Epidemiology Research, Data Science...
Saved in:
Main Authors: | Yamabe K (Author), Liebert R (Author), Flores N (Author), Pashos CL (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Health-related quality of life outcomes, economic burden, and associated costs among diagnosed and undiagnosed depression patients in Japan
by: Yamabe K, et al.
Published: (2019) -
Health-related outcomes and economic burden in Japan: focus on inflammatory bowel disease, multiple sclerosis, and depression
by: Yamabe K
Published: (2018) -
Health-related outcomes, health care resource utilization, and costs of multiple sclerosis in Japan compared with US and five EU countries
by: Yamabe K, et al.
Published: (2019) -
Family caregiving in dementia and its impact on quality of life and economic burden in Japan-web based survey
by: Ataru Igarashi, et al.
Published: (2020) -
COMPLIANCE AND QUALITY OF LIFE OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES
by: R.J. JAMOLOVA, et al.
Published: (2024)